---
id: FC-016
type: Flashcard
created: 2025-08-08 09:58:35.047407
tags:
- Flashcard
- question
- psychiatry
topic: psychiatry
answer: A
related_articles:
- title: Effectiveness of ICS/LABA Compared With SABA as Relief Medications for Asthma.
  path: 2023/2023-11-effectiveness-of-ics-laba-compared-with-saba-as-relief-medic.md
  similarity: 1.0
  link: '[[2023/2023-11-effectiveness-of-ics-laba-compared-with-saba-as-relief-medic|Effectiveness
    of ICS/LABA Compared With SABA as Relief Medications for Asthma.]]'
- title: Effectiveness of ICS/LABA Compared With SABA as Relief Medications for Asthma.
  path: 2023/2023-11-effectiveness-of-icslaba-compared-with-saba-as-relief-medica.md
  similarity: 1.0
  link: '[[2023/2023-11-effectiveness-of-icslaba-compared-with-saba-as-relief-medica|Effectiveness
    of ICS/LABA Compared With SABA as Relief Medications for Asthma.]]'
- title: Adding a LABA or LAMA to Current ICS Therapy for Uncontrolled Asthma.
  path: 2024/2024-10-adding-a-laba-or-lama-to-current-ics-therapy-for-uncontrolle.md
  similarity: 0.5
  link: '[[2024/2024-10-adding-a-laba-or-lama-to-current-ics-therapy-for-uncontrolle|Adding
    a LABA or LAMA to Current ICS Therapy for Uncontrolled Asthma.]]'
- title: BioFire Respiratory Panel for the Detection of Viruses and Bacteria.
  path: 2023/2023-08-biofire-respiratory-panel-for-the-detection-of-viruses-and-b.md
  similarity: 0.5
  link: '[[2023/2023-08-biofire-respiratory-panel-for-the-detection-of-viruses-and-b|BioFire
    Respiratory Panel for the Detection of Viruses and Bacteria.]]'
- title: Airflow Reversibility in Patients With Asthma.
  path: 2024/2024-04-airflow-reversibility-in-patients-with-asthma.md
  similarity: 0.5
  link: '[[2024/2024-04-airflow-reversibility-in-patients-with-asthma|Airflow Reversibility
    in Patients With Asthma.]]'
topics:
- Pediatrics
- Psychiatry
- Pulmonology
---

# Flashcard FC-016

## Question

which one of the followingmedicationsisfirst-linetherapyforcontrol(i.e.,maintenance)ofasthma? Inhaledcorticosteroids. Long-actingmuscarinicantagonists. Leukotrienereceptorantagonists. Long-actingbeta2 agonists. @ Back

## Answer

**A**

## Explanation

Inhaledcorticosteroidsarethemosteffectivecontrollermedications;theydecreaseasthma exacerbations(relativerisk0.46;95 Cl,0.34 to.0.62),hospitalizationrate(relativerisk-0.5;95 Cl, 0.4 to0.6),andtheneedforrelievermedications. Commonadverseeffectsarelocalizedandminimal. Long-actingbetaagonistsarethefirstchoiceadd-oncontrollermedicationforusewithaninhaled corticosteroid. Long-actingbetayagonistmonotherapycarriesa U. S. Foodand Drug Administration boxedwarningbecauseofdataassociatedwithincreasedriskofdeath,intubation,andhospitalization andisnotrecommended. Long-actingmuscarinicantagonistsandleukotrienereceptorantagonistsare second-linecontrollertherapies. e

## References

- AAFPQuestion Bank-Pythonsimplecapture.

